Ohcanbohtosat - Gisèle Bonne

Aiddostahte ozu
  1. 1
    Emery–Dreifuss muscular dystrophy, laminopathies, and other nuclear envelopathies

    Emery–Dreifuss muscular dystrophy, laminopathies, and other nuclear envelopathies Dahkki Gisèle Bonne, Susana Quijano-Roy

    Almmustuhtton 2013
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    “Laminopathies”: A wide spectrum of human diseases

    “Laminopathies”: A wide spectrum of human diseases Dahkki Howard J. Worman, Gisèle Bonne

    Almmustuhtton 2007
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Emery-Dreifuss muscular dystrophy

    Emery-Dreifuss muscular dystrophy Dahkki A. Leclerc, Gisèle Bonne, Ketty Schwartz

    Almmustuhtton 2002
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    The 2018 version of the gene table of monogenic neuromuscular disorders (nuclear genome)

    The 2018 version of the gene table of monogenic neuromuscular disorders (nuclear genome) Dahkki Gisèle Bonne, François Rivier, Dalil Hamroun

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome

    Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome Dahkki Rachel Thompson, Gisèle Bonne, Paolo Missier, Hanns Lochmüller

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    The 2020 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2020 version of the gene table of neuromuscular disorders (nuclear genome) Dahkki Louise Benarroch, Gisèle Bonne, François Rivier, Dalil Hamroun

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    The 2021 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2021 version of the gene table of neuromuscular disorders (nuclear genome) Dahkki Louise Benarroch, Gisèle Bonne, François Rivier, Dalil Hamroun

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    The 2022 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2022 version of the gene table of neuromuscular disorders (nuclear genome) Dahkki Enzo Cohen, Gisèle Bonne, François Rivier, Dalil Hamroun

    Almmustuhtton 2021
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    The 2023 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2023 version of the gene table of neuromuscular disorders (nuclear genome) Dahkki Louise Benarroch, Gisèle Bonne, François Rivier, Dalil Hamroun

    Almmustuhtton 2022
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    The 2024 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2024 version of the gene table of neuromuscular disorders (nuclear genome) Dahkki Louise Benarroch, Gisèle Bonne, François Rivier, Dalil Hamroun

    Almmustuhtton 2023
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Expression of human cytochrome <i>c</i>, oxidase subunits during fetal development

    Expression of human cytochrome <i>c</i>, oxidase subunits during fetal development Dahkki Gisèle Bonne, Peter Seibel, Stefanie Possekel, C. Marsac, Bernhard Kadenbach

    Almmustuhtton 1993
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Mitogen-Activated Protein Kinase Inhibitors Improve Heart Function and Prevent Fibrosis in Cardiomyopathy Caused by Mutation in Lamin A/C Gene

    Mitogen-Activated Protein Kinase Inhibitors Improve Heart Function and Prevent Fibrosis in Cardiomyopathy Caused by Mutation in Lamin A/C Gene Dahkki Wei Wu, Antoine Muchir, Jian Shan, Gisèle Bonne, Howard J. Worman

    Almmustuhtton 2010
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene

    Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene Dahkki Wei Wu, Jian Shan, Gisèle Bonne, Howard J. Worman, Antoine Muchir

    Almmustuhtton 2010
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery–Dreifuss muscular dystrophy

    Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery–Dreifuss muscular dystrophy Dahkki Antoine Muchir, Paul Pavlidis, Gisèle Bonne, Yukiko Hayashi, Howard J. Worman

    Almmustuhtton 2007
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins

    Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins Dahkki Antoine Muchir, Jing Shan, Gisèle Bonne, Stephan E. Lehnart, Howard J. Worman

    Almmustuhtton 2008
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    ColVI myopathies: where do we stand, where do we go?

    ColVI myopathies: where do we stand, where do we go? Dahkki Valérie Allamand, Laura Briñas, Pascale Richard, Tanya Stojkovic, Susana Quijano‐Roy, Gisèle Bonne

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Autophagic degradation of nuclear components in mammalian cells

    Autophagic degradation of nuclear components in mammalian cells Dahkki Young-Eun Park, Yukiko Hayashi, Gisèle Bonne, Takuro Arimura, S. Noguchi, Ikuya Nonaka, Ichizo Nishino

    Almmustuhtton 2009
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Primary Prevention of Sudden Death in Patients with Lamin A/C Gene Mutations

    Primary Prevention of Sudden Death in Patients with Lamin A/C Gene Mutations Dahkki Christophe Meune, Jop H. van Berlo, Frédéric Anselme, Gisèle Bonne, Yigal M. Pinto, Denis Duboc

    Almmustuhtton 2006
    Viečča ollesdeavstta Viečča ollesdeavstta
    Carta
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy

    Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy Dahkki Anne-Claire Guénantin, Imen Jebeniani, Julia Leschik, Erwan Watrin, Gisèle Bonne, Nicolas Vignier, Michel Pucéat

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene

    Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene Dahkki Antoine Muchir, Sarah A Reilly, W. Wu, Shinichi Iwata, Shunichi Homma, Gisèle Bonne, Howard J. Worman

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: